DeepSeek app unavailable in Apple and Google app stores in Italy

DeepSeek app unavailable in Apple and Google app stores in Italy


The Chinese artificial intelligence application DeepSeek appeared to be unavailable on Wednesday in Apple and Google app stores in Italy on Wednesday.

A notice displayed to customers on Apple’s App Store said the app was “currently not available in the country or area you are in. A message on the Google app platform, said the download “was not supported” in Italy.

DeepSeek was still working on Wednesday in other European countries and in Britain.

The disappearance came after Italy’s data protection authority said on Tuesday it was seeking answers from DeepSeek on its use of personal data.

The Italian regulator, also known as the Garante, said it wanted to know what personal data is collected, from which sources, for what purposes, on what legal basis, and whether it is stored in China.



Source

Ex-Google CEO Eric Schmidt warns AI models can be hacked: ‘They learn how to kill someone’
World

Ex-Google CEO Eric Schmidt warns AI models can be hacked: ‘They learn how to kill someone’

Google’s former CEO Eric Schmidt spoke at the Sifted Summit on Wednesday 8, October. Bloomberg | Bloomberg | Getty Images Google‘s former CEO Eric Schmidt has issued a stark reminder about the dangers of AI and how susceptible it is to being hacked. Schmidt, who served as Google’s chief executive from 2001 to 2011, warned […]

Read More
Rare earths stocks surge after China tightens grip on global supplies
World

Rare earths stocks surge after China tightens grip on global supplies

A wheel loader operator fills a truck with ore at the MP Materials rare earth mine in Mountain Pass, California, U.S. January 30, 2020. Steve Marcus | Reuters Shares of U.S. rare earth and critical mineral miners surged Thursday after China tightened restrictions on exports, fuelling market speculation that the Trump administration will move more […]

Read More
Novo Nordisk shares slip after pharma giant announces .7 billion U.S. acquisition
World

Novo Nordisk shares slip after pharma giant announces $4.7 billion U.S. acquisition

LONDON — Shares of Danish pharmaceutical giant Novo Nordisk fell 1.1% on Thursday after the company announced plans to acquire U.S. biotech firm Akero Therapeutics. The deal will see Novo pay $54 per share, valuing Akero at $4.7 billion, with the acquisition also including a contingent value right of $6 per share, potentially adding another […]

Read More